Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Critical Reviews in Oncology/Hematology|June 15, 2025
Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidanceMarta Toledano-Fonseca, Elena Brozos-Vázquez, María Victoria García-Ortiz, et al.
Clinical Colorectal Cancer|September 10, 2013
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumabJavier Sastre, Marta Vidaurreta, Auxiliadora Gómez, et al.
International Journal of Molecular Sciences|August 28, 2025
Immune Modulation Through KIR-HLA Interactions Influences Cetuximab Efficacy in Colorectal CancerMaría Gómez-Aguilera, Bárbara Manzanares-Martín, Arancha Cebrián-Aranda, et al.
Clinical Breast Cancer|August 14, 2010
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II studyJuan de la Haba-Rodriguez, Rosario González Mancha, Gumersindo Pérez Manga, et al.
International Journal of Clinical and Health Psychology : IJCHP|March 12, 2026
The use of mHealth technologies to support acceptance and commitment therapy in cancer patients: Preliminary results from a randomized controlled trialFrancisco García-Torres, Margarita García-Carmona, Ángel Gómez-Solís, et al.
Cancer Treatment Reviews|March 15, 2024
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selectionElena Brozos-Vázquez, Marta Toledano-Fonseca, Nicolás Costa-Fraga, et al.
Cancer|February 10, 2010
Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedicationSalvatore Siena, Robert Glynne-Jones, Antoine Adenis, et al.
Medcomm|April 3, 2026
<i>NR3C1</i>, <i>LAX1</i>, and <i>RCAN3</i> as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic CancerPablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano-Osuna, et al.
Toxicology and Applied Pharmacology|October 11, 2016
Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patientsOctavio Caba, Antonio Irigoyen, Cristina Jimenez-Luna, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2023
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statementCristina Grávalos, Fernando Pereira, Ruth Vera, et al.
Pageof 15